Ordinary Shares · CUSIP N62509109 · who reports it, how much, and how much it matters to them
30 of the 720 hedge fund managers we track reported shares of NewAmsterdam Pharma Co N.V. (Nasdaq: NAMS) on Form 13F for 30 June 2026. Between them they reported USD 858m. The largest position belongs to Ra Capital Management, at USD 324m. The manager with the most riding on it is Artia Global Partners, where it is 3.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ra Capital Management1 fund on PPLI.com | USD 324m | 2.8% |
| 2 | Viking Global Investors4 funds on PPLI.com | USD 142m | 0.4% |
| 3 | Maverick Capital20 funds on PPLI.com | USD 111m | 1.0% |
| 4 | Polar Capital LLP26 funds on PPLI.com | USD 58m | 0.1% |
| 5 | Castle Hook Partners1 fund on PPLI.com | USD 46m | 0.2% |
| 6 | Citadel Advisors32 funds on PPLI.com | USD 22m | 0.0% |
| 7 | Rock Springs Capital Management2 funds on PPLI.com | USD 20m | 1.0% |
| 8 | Adage Capital Management1 fund on PPLI.com | USD 19m | 0.0% |
| 9 | Artia Global Partners1 fund on PPLI.com | USD 17m | 3.2% |
| 10 | Millennium Management6 funds on PPLI.com | USD 17m | 0.0% |
| 11 | Cormorant Asset Management1 fund on PPLI.com | USD 17m | 0.9% |
| 12 | Slate Path Capital3 funds on PPLI.com | USD 11m | 0.1% |
| 13 | Exoduspoint Capital Management7 funds on PPLI.com | USD 10m | 0.1% |
| 14 | Eversept Partners3 funds on PPLI.com | USD 9.3m | 0.5% |
| 15 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 7.2m | 0.3% |
| 16 | POINT72 Asset Management17 funds on PPLI.com | USD 5.7m | 0.0% |
| 17 | D. E. Shaw & Co.15 funds on PPLI.com | USD 4.1m | 0.0% |
| 18 | Walleye Capital8 funds on PPLI.com | USD 3.8m | 0.0% |
| 19 | Squarepoint Ops7 funds on PPLI.com | USD 3.1m | 0.0% |
| 20 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 3m | 0.0% |
| 21 | Tudor Investment Corporation10 funds on PPLI.com | USD 2.7m | 0.0% |
| 22 | Palo Alto Investors6 funds on PPLI.com | USD 1.5m | 0.2% |
| 23 | Boothbay Fund Management2 funds on PPLI.com | USD 1.2m | 0.0% |
| 24 | HighVista Strategies27 funds on PPLI.com | USD 708,000 | 0.2% |
| 25 | Engineers Gate Manager1 fund on PPLI.com | USD 662,000 | 0.0% |
| 26 | Two Sigma Investments35 funds on PPLI.com | USD 407,000 | 0.0% |
| 27 | Brevan Howard Capital Management39 funds on PPLI.com | USD 324,000 | 0.0% |
| 28 | Persistent Asset Partners10 funds on PPLI.com | USD 247,000 | 0.1% |
| 29 | The Quarry1 fund on PPLI.com | USD 154,000 | 0.0% |
| 30 | Bayforest Capital1 fund on PPLI.com | USD 43,278 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Artia Global Partners | USD 17m | 3.2% |
| 2 | Ra Capital Management | USD 324m | 2.8% |
| 3 | Maverick Capital | USD 111m | 1.0% |
| 4 | Rock Springs Capital Management | USD 20m | 1.0% |
| 5 | Cormorant Asset Management | USD 17m | 0.9% |
| 6 | Eversept Partners | USD 9.3m | 0.5% |
| 7 | Viking Global Investors | USD 142m | 0.4% |
| 8 | Arrowmark Colorado Holdings | USD 7.2m | 0.3% |
| 9 | Castle Hook Partners | USD 46m | 0.2% |
| 10 | Palo Alto Investors | USD 1.5m | 0.2% |
NewAmsterdam Pharma Co N.V. trades under the symbol NAMS on the Nasdaq. Its CUSIP, the code used on Form 13F, is N62509109.
30 of the 720 hedge fund managers PPLI.com tracks reported NewAmsterdam Pharma Co N.V. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 324m), Viking Global Investors (USD 142m), Maverick Capital (USD 111m), Polar Capital LLP (USD 58m) and Castle Hook Partners (USD 46m).
30 managers in our coverage reported it, and between them they run 341 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Artia Global Partners, where the position was 3.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with NewAmsterdam Pharma Co N.V. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.